Skip to content
Search

Latest Stories

‘Medical misogyny is leaving women in pain,’ says WEC chair Sarah Owen MP

Women with reproductive health conditions wait years for treatment
Young adult woman holding her crotch (gettyimages)

Women with reproductive health conditions wait years for treatmentand in many cases face trauma-inducing procedures

There’s a “clear lack of awareness and understanding” of women's reproductive health conditions such as endometriosis, adenomyosis and heavy menstrual bleeding among primary healthcare practitioners, despite their widespread prevalence in the UK, according to a new report by the Women and Equalities Committee (WEC).

This is causing considerable delays in diagnosis and treatment, leaving women and girls to “suck it up” and endure pain and discomfort, it stated.


The report identifies pervasive stigma associated with gynaecological and urogynaecological health, a lack of education and ‘medical misogyny’ as factors contributing to poor awareness of these conditions.

Labour MP Sarah Owen, chair of the Committee, said: “Our inquiry has shown misogyny in medicine is leaving women in pain and their conditions undiagnosed.”

“Women are finding their symptoms dismissed, are waiting years for life changing treatment and in too many cases are being put through trauma-inducing procedures. All the while, their conditions worsen and become more complicated to treat.”

Owen highlighted the high prevalence of these conditions, noting that “up to one in three women live with heavy menstrual bleeding, one in ten have a condition such as endometriosis or adenomyosis.”

Key recommendations for improvement

The WEC outlined several urgent recommendations to address these issues:

Training for healthcare practitioners

The NHS should urgently implement a training programme to improve the experience of accessing treatment and diagnosis for women and girls with reproductive ill health.

Owen suggested that improving early diagnosis, including follow-up appointments, should be a key performance indicator for the Women’s Health Strategy for England.

Increased funding for training 

The Department of Health and Social Care (DHSC) should set out plans to improve the accessibility and take up of professional development in women's reproductive health conditions among practitioners in primary care, including increased funding for training and protected time for GPs to undertake it.

The government should also explore ways to incentivise healthcare professionals to specialise in women's reproductive health, including making obstetrics and gynaecology a mandatory rotation in training.

Mental health support

Women and girls with suspected or diagnosed reproductive health conditions should be offered specialist mental health support.

Keeping practitioners informed  

The NHS should ensure that healthcare practitioners remain up to date with the full range of diagnostic and treatment options available for reproductive health conditions. Patients should also be fully informed about their options.

Comprehensive education

The committee also raised concerns that menstrual health education in schools is “insufficient and inconsistent”, often delivered too late to be of use.

It found that girls are leaving school without understanding what constitutes a ‘normal’ period, unequipped to spot the symptoms of reproductive health conditions.

The report calls for:

  • Effective training for teachers delivering menstrual and gynaecological health education.
  • Information to be delivered around the time most girls first experience menstruation.
  • Boys to be educated about female reproductive health conditions, with an emphasis on intersectional differences.

Prevent misinformation

The report cautioned about women and girls using online spaces to seek help. It recommends that the NHS and other trusted sources become the first port-of-call to prevent misinformation. The NHS website, app, and social media platforms should be comprehensive, accessible, inclusive, and highly visible.

Investing in women’s health hubs

The expansion of the women’s health hub model was identified as a potential key step towards providing integrated care to effectively support women experiencing reproductive health conditions.

The committee urged the government to allocate long-term, ring-fenced funding and resources to embed and develop the hub model, including increased provision of ultrasound facilities that can aid diagnosis.

Studies cited in the report suggest that increased funding for gynaecology could yield a significant return on investment.

Supporting research and reducing diagnosis delays

The WEC also called for increased funding to support research into the causes, diagnosis, and treatment of women’s reproductive health conditions. It recommended NHS England and research bodies explore ways to attract more clinical researchers to this field.

The report specifically urged the government to reduce the waiting times for an endometriosis diagnosis to under two years by the end of this Parliament and to improve the understanding and treatment of heavy menstrual bleeding within the same period.

More For You

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less